Jazz Pharmaceuticals PLC (NAS:JAZZ)
$ 121.59 -1.05 (-0.86%) Market Cap: 7.35 Bil Enterprise Value: 10.93 Bil PE Ratio: 17.13 PB Ratio: 1.76 GF Score: 85/100

Jazz Pharmaceuticals PLC at JPMorgan Healthcare Conference Transcript

Jan 13, 2020 / 06:00PM GMT
Release Date Price: $145.85 (-0.57%)
Jessica Macomber Fye
JP Morgan Chase & Co, Research Division - Analyst

Great. Good morning, everyone. My name is Jess Fye. I'm one of the biotech analysts at JPMorgan. And we're continuing the 2020 Health Care Conference this morning with Jazz Pharmaceuticals. Speaking for Jazz is going to be the company's Chairman and CEO, Bruce Cozadd. And right after this, we're going to go across the hall to the Georgian room for a breakout session where we're going to do some Q&A. You can follow me over there. Looking forward to hearing some interesting updates from Jazz.

Bruce C. Cozadd
Jazz Pharmaceuticals plc - Co-Founder, Chairman & CEO

Great. Good morning, everyone. So I'm thrilled to be back for my 29th consecutive JPMorgan Conference, one of my favorite weeks of every year. And I've the distinct privilege of providing an update on Jazz Pharmaceuticals progress. And I have to say in 2019, thanks to the passion, the innovation, the integrity, the collaboration and the pursuit of excellence on the part of our 1,560 dedicated and talented employees, we

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot